Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

7th Closed Expert Meeting of the Editorial Board

25th August 2017, Barcelona, Spain

An update on inclisiran

An update on inclisiran

Reports from the 7th Expert Meeting of PCSK9 Forum Kausik Ray

read more »
An update on cardiovascular disease, depression and adherence

An update on cardiovascular disease, depression and adherence

Reports from the 7th Expert Meeting of PCSK9 Forum David Hare

read more »
A background to siRNA: Pushkal Garg, Alnylam

A background to siRNA: Pushkal Garg, Alnylam

Reports from the 7th Expert Meeting of PCSK9 Forum Pushkal Garg 

read more »
How do we identify very high risk patients for PCSK9 inhibition? Part Two

How do we identify very high risk patients for PCSK9 inhibition? Part Two

Reports from the 7th Expert Meeting of PCSK9 Forum The role of imaging: Ulf Landmesser, Charité Universitätsmedizin Berlin, Germany

read more »
How do we identify very high risk patients for PCSK9 inhibition? Part One

How do we identify very high risk patients for PCSK9 inhibition? Part One

Reports from the 7th Expert Meeting of PCSK9 Forum Clinical profiling: Erik Stroes, Academic Medical Center, the Netherlands

read more »
Profiling patients with ACS: What are the prospects for PCSK9 inhibition?

Profiling patients with ACS: What are the prospects for PCSK9 inhibition?

Reports from the 7th Expert Meeting of PCSK9 Forum Gregory G. Schwartz, VA Medical Center and University of Colorado School of Medicine, Denver

read more »
PCSK9 and the beta-cell

PCSK9 and the beta-cell

PCSK9 is expressed in human pancreatic islets, where it down-regulates LDLR expression. But what are the effects of PCSK9-deficiency on glucose homeostasis and insulin secretion? Dr Betrand Cariou (l’Institut du Thorax Université de Nantes, France) overviews the evidence from studies to date.

read more »
Intracellular actions of PCSK9

Intracellular actions of PCSK9

Reports from the 7th Expert Meeting of PCSK9 Forum The hepatic extracellular function of PCSK9 in inhibiting the LDL receptor is now well established. With the development of novel agents that block PCSK9 synthesis upstream, investigation of intracellular actions of PCSK9 is a new focus…

read more »